Syngeneic mouse model of epithelial ovarian cancer: effects of nanoparticulate paclitaxel, Nanotax.
Roby
Katherine F
KF
Department of Anatomy & Cell Biology, University of Kansas Medical Center, Kansas City, USA. kroby@kumc.edu
Niu
Fenghui
F
Rajewski
Roger A
RA
Decedue
Charles
C
Subramaniam
Bala
B
Terranova
Paul F
PF
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D004195:Disease Models, Animal; D016503:Drug Delivery Systems / Q000379:methods*; D005260:Female; D006801:Humans; D015552:Injections, Intralesional; D007274:Injections, Intraperitoneal; D051379:Mice; D053758:Nanoparticles / Q000627:therapeutic use*; D009375:Neoplasms, Glandular and Epithelial / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel / Q000008:administration & dosage*; D014185:Transplantation, Isogeneic
D000970:Antineoplastic Agents; D017239:Paclitaxel